Sun Pharmaceutical Industries has reported results for second quarter ended September 30, 2024 (Q2FY25).

The company has reported 2.85% fall in net profit at Rs 863.29 crore for Q2FY25 as compared to Rs 888.63 crore for the same quarter in the previous year. However, total income of the company increased by 0.22% at Rs 5214.01 crore for Q2FY25 as compared to Rs 5202.75 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 27.98% rise in its net profit at Rs 3040.16 crore for the quarter ended September 30, 2024 as compared to Rs 2375.51 crore for the same quarter in the previous year. Total income of the company increased by 9.29% at Rs 13645.39 crore for Q2FY25 as compared to Rs 12486.02 crore for the corresponding quarter previous year.